Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Financials | 13.25% |
| 4 | Healthcare | 11.94% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Hamilton Lane
HLNE
$3.83B
| $852K | ﹤0.01% |
+17,759
| New | +$781K |
|
577
Etsy
ETSY
$7.96B
| $844K | ﹤0.01% |
20,013
-3,002
| -13% | -$97.7K |
|
578
Credicorp
BAP
$31.1B
| $829K | ﹤0.01% |
3,682
+22
| +0.6% | +$5K |
|
579
Adtran
ADTN
$769M
| $827K | ﹤0.01% |
55,680
-1,992
| -3% | -$29.7K |
|
|
GMS
580
DELISTED
GMS Inc
GMS
| $804K | ﹤0.01% |
29,679
+14,541
| +96% | +$441K |
|
|
TBI
581
Trueblue
TBI
$237M
| $789K | ﹤0.01% |
29,267
-1,048
| -3% | -$27.8K |
|
582
Matthews International
MATW
$878M
| $772K | ﹤0.01% |
13,124
-463
| -3% | -$24.7K |
|
583
Designer Brands
DBI
$298M
| $768K | ﹤0.01% |
29,738
-50,812
| -63% | -$1.21M |
|
584
Cheesecake Factory
CAKE
$4.32B
| $755K | ﹤0.01% |
+13,710
| New | +$726K |
|
|
HES
585
DELISTED
Hess
HES
| $751K | ﹤0.01% |
11,234
+6,380
| +131% | +$381K |
|
586
NOV
NOV
$7.35B
| $737K | ﹤0.01% |
16,984
+10,586
| +165% | +$428K |
|
587
Medpace
MEDP
$16.5B
| $693K | ﹤0.01% |
+16,113
| New | +$651K |
|
588
Occidental Petroleum
OXY
$54.6B
| $688K | ﹤0.01% |
+8,226
| New | +$657K |
|
|
WBT
589
DELISTED
Welbilt, Inc.
WBT
| $683K | ﹤0.01% |
+30,623
| New | +$612K |
|
590
AutoZone
AZO
$50.2B
| $682K | ﹤0.01% |
+1,016
| New | +$656K |
|
591
D.R. Horton
DHI
$41.3B
| $680K | ﹤0.01% |
+16,576
| New | +$715K |
|
|
GNMK
592
DELISTED
GenMark Diagnostics, Inc
GNMK
| $676K | ﹤0.01% |
105,960
-86,248
| -45% | -$570K |
|
593
Watts Water Technologies
WTS
$11.5B
| $675K | ﹤0.01% |
8,610
-310
| -3% | -$24.1K |
|
|
ONC
594
BeOne Medicines Ltd
ONC
$33.8B
| $674K | ﹤0.01% |
+4,384
| New | +$782K |
|
595
Sally Beauty Holdings
SBH
$1.43B
| $673K | ﹤0.01% |
+41,979
| New | +$668K |
|
596
ON Semiconductor
ON
$34.7B
| $658K | ﹤0.01% |
+29,611
| New | +$716K |
|
597
Semtech
SMTC
$11.3B
| $650K | ﹤0.01% |
13,812
-19,964
| -59% | -$895K |
|
598
Yum! Brands
YUM
$40.7B
| $649K | ﹤0.01% |
+8,293
| New | +$692K |
|
|
MRO
599
DELISTED
Marathon Oil Corporation
MRO
| $633K | ﹤0.01% |
30,344
+19,415
| +178% | +$383K |
|
600
TransDigm Group
TDG
$71.9B
| $632K | ﹤0.01% |
1,832
-335
| -15% | -$110K |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.95B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.